Biogen Pulls EU Filing For Aduhelm But Stands By Alzheimer’s Drug
The marketing application was withdrawn before the European Medicines Agency had finished re-examining its earlier recommendation to reject the drug.
The marketing application was withdrawn before the European Medicines Agency had finished re-examining its earlier recommendation to reject the drug.